Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 7
Submit an article Journal homepage
443
Views
3
CrossRef citations to date
0
Altmetric
Commentary

Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the ‘real world’

Prithviraj BoseDepartment of Leukemia, MD Anderson Cancer Center, Houston, TX, USA; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-4343-5712
ORCID Icon,
Lisa S. ChenDepartment of Experimental Therapeutics, MD Anderson Cancer Center, Houston, TX, USA
&
Varsha GandhiDepartment of Leukemia, MD Anderson Cancer Center, Houston, TX, USA; ;Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3172-9166
ORCID Icon
Pages 1603-1605 | Received 11 Jan 2019, Accepted 13 Jan 2019, Published online: 06 Feb 2019

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rania S. Khelifi, Steven J. Huang, Kerry J. Savage, Diego Villa, David W. Scott, Khaled Ramadan, Joseph M. Connors, Laurie H. Sehn, Cynthia L. Toze & Alina S. Gerrie. (2023) Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, Canada. Leukemia & Lymphoma 64:6, pages 1129-1138.
Read now

Articles from other publishers (2)

Versha Banerji. (2022) With great power comes great responsibility: Managing side effects of novel treatments in chronic lymphocytic leukemia (CLL). Canadian Hematology Today.
Crossref
Subir Roy Chowdhury, Cheryl Peltier, Sen Hou, Amandeep Singh, James B. Johnston, Spencer B. Gibson, Aaron J. Marshall & Versha Banerji. (2021) Ex Vivo Mitochondrial Respiration Parallels Biochemical Response to Ibrutinib in CLL Cells. Cancers 13:2, pages 354.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.